Howard Horn
Chief Financial Officer · 4 filings · Latest: Jun 1, 2026
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RARE | Howard Horn | Chief Financial Officer | Jun 1, 2026 | Sale | $23.77 | 4,653 | $110.6K | 105,689 | |
RARE | Howard Horn | Chief Financial Officer | May 1, 2026 | Sale | $24.90 | 4,683 | $116.6K | 110,342 | |
RARE | Howard Horn | Chief Financial Officer | Apr 16, 2026 | Grant/Award | $0.00 | 34,674 | — | 115,025 | |
RARE | Howard Horn | Chief Financial Officer | Apr 1, 2026 | Sale | $20.97 | 4,683 | $98.2K | 80,351 |